Neuberger Berman Group LLC Has $50.31 Million Stock Holdings in Novanta Inc. $NOVT

Neuberger Berman Group LLC cut its holdings in Novanta Inc. (NASDAQ:NOVT) by 2.8% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 502,308 shares of the technology company’s stock after selling 14,606 shares during the period. Neuberger Berman Group LLC owned about 1.40% of Novanta worth $50,306,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Barclays PLC increased its position in shares of Novanta by 14.8% during the 3rd quarter. Barclays PLC now owns 89,925 shares of the technology company’s stock worth $9,006,000 after purchasing an additional 11,619 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in Novanta by 1.8% in the third quarter. Dimensional Fund Advisors LP now owns 594,936 shares of the technology company’s stock valued at $59,582,000 after acquiring an additional 10,295 shares during the last quarter. Victory Capital Management Inc. grew its position in shares of Novanta by 4.5% in the 3rd quarter. Victory Capital Management Inc. now owns 148,113 shares of the technology company’s stock valued at $14,834,000 after acquiring an additional 6,426 shares during the period. Segall Bryant & Hamill LLC grew its position in shares of Novanta by 2.5% in the 3rd quarter. Segall Bryant & Hamill LLC now owns 103,583 shares of the technology company’s stock valued at $10,374,000 after acquiring an additional 2,529 shares during the period. Finally, 111 Capital acquired a new position in shares of Novanta during the 3rd quarter worth about $215,000. Institutional investors and hedge funds own 98.35% of the company’s stock.

Analyst Ratings Changes

NOVT has been the topic of a number of research analyst reports. Weiss Ratings raised shares of Novanta from a “sell (d+)” rating to a “hold (c-)” rating in a report on Tuesday, January 20th. Zacks Research upgraded Novanta from a “strong sell” rating to a “hold” rating in a report on Friday, January 16th. Finally, Robert W. Baird set a $150.00 price target on Novanta in a research report on Wednesday, February 25th. Three research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $150.00.

Insider Buying and Selling

In related news, CEO Matthijs Glastra sold 7,500 shares of the business’s stock in a transaction that occurred on Tuesday, February 10th. The stock was sold at an average price of $145.04, for a total value of $1,087,800.00. Following the completion of the sale, the chief executive officer directly owned 57,367 shares in the company, valued at approximately $8,320,509.68. The trade was a 11.56% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Robert Buckley sold 1,423 shares of the stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $140.88, for a total value of $200,472.24. Following the sale, the chief financial officer directly owned 93,814 shares in the company, valued at $13,216,516.32. This represents a 1.49% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 24,346 shares of company stock valued at $3,382,737. 1.20% of the stock is owned by company insiders.

Novanta Price Performance

NASDAQ:NOVT opened at $131.22 on Friday. Novanta Inc. has a 52 week low of $98.27 and a 52 week high of $149.95. The company has a debt-to-equity ratio of 0.16, a quick ratio of 2.80 and a current ratio of 3.69. The firm’s 50-day simple moving average is $134.88 and its 200 day simple moving average is $121.00. The firm has a market cap of $4.68 billion, a price-to-earnings ratio of 89.88 and a beta of 1.61.

Novanta (NASDAQ:NOVT) last posted its quarterly earnings data on Monday, February 23rd. The technology company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.88 by $0.03. Novanta had a net margin of 5.49% and a return on equity of 13.12%. The firm had revenue of $258.35 million during the quarter, compared to the consensus estimate of $260.72 million. During the same quarter in the previous year, the firm posted $0.76 EPS. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q1 2026 guidance at 0.750-0.800 EPS. As a group, sell-side analysts predict that Novanta Inc. will post 3.03 earnings per share for the current year.

Novanta Profile

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.